Should radioiodine now be first line treatment for Graves’ disease?
Crossref DOI link:
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Okosieme, Onyebuchi E.
Taylor, Peter N.
Dayan, Colin M.
Text and Data Mining valid from 2020-03-09
Version of Record valid from 2020-03-09
27 November 2019
27 February 2020
9 March 2020
Ethics approval and consent to participate
The authors declare that they have no competing interests.